Exosome nanotechnology: An emerging paradigm shift in drug delivery: Exploitation of exosome nanovesicles for systemic in vivo delivery of RNAi heralds new horizons for drug delivery across biological barriers

BioEssays

Volumn 33, Issue 10, 2011, Pages 737-741

  Lakhal, Samira ^a   Wood, Matthew J A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Blood brain barrier; Dendritic cells; Exosomes; RNAi; Stem cells

Indexed keywords

AMYLOID BETA PROTEIN; CERAMIDE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MESSENGER RNA; MICRORNA; SMALL INTERFERING RNA; SPHINGOMYELIN; VIRUS GLYCOPROTEIN;

ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; COLORECTAL CANCER; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG DELIVERY SYSTEM; DRUG TARGETING; EMBRYONIC STEM CELL; EXOSOME; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HUMAN CELL; IMMUNOGENICITY; INJECTION; MESENCHYMAL STEM CELL; NANOTECHNOLOGY; NONHUMAN; REPERFUSION INJURY; RNA INTERFERENCE; SKIN FIBROBLAST; STEM CELL; TISSUE REGENERATION; TISSUE REPAIR;

BLOOD-BRAIN BARRIER; DENDRITIC CELLS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EXOSOMES; GLYCOPROTEINS; HUMANS; NANOTECHNOLOGY; PHARMACEUTICAL PREPARATIONS; RABIES VIRUS; RNA INTERFERENCE; VIRAL PROTEINS;

EID: 80052831943     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201100076     Document Type: Article

References (27)

1. Trajkovic K, Hsu C, Chiantia S, Rajendran L, et al. 2008. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319: 1244-7.
2. Laulagnier K, Grand D, Dujardin A, Hamdi S, et al. 2004. PLD2 is enriched on exosomes and its activity is correlated to the release of exosomes. FEBS Lett 572: 11-4.
3. Alonso R, Mazzeo C, Rodriguez MC, Marsh M, et al. 2011. Diacylglycerol kinase alpha regulates the formation and polarisation of mature multivesicular bodies involved in the secretion of Fas ligand-containing exosomes in T lymphocytes. Cell Death Differ 18: 1161-73.
4. Pan BT, Johnstone RM. 1983. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 33: 967-78.
5. Simpson RJ, Jensen SS, Lim JW. 2008. Proteomic profiling of exosomes: current perspectives. Proteomics 8: 4083-99.
6. Valadi H, Ekstrom K, Bossios A, Sjostrand M, et al. 2007. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-9.
7. Gibbings DJ, Ciaudo C, Erhardt M, Voinnet O. 2009. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol 11: 1143-9.
8. Simpson RJ, Lim JW, Moritz RL, Mathivanan S. 2009. Exosomes: proteomic insights and diagnostic potential. Exp Rev Prot 6: 267-83.
9. Nazarenko I, Rana S, Baumann A, Mcalear J, et al. Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res 70: 1668-78.
10. Lotvall J, Valadi H. 2007. Cell to cell signalling via exosomes through esRNA. Cell Adh Mig 1: 156-8.
11. Fevrier B, Raposo G. 2004. Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 16: 415-21.
12. Schorey JS, Bhatnagar S. 2008. Exosome function: from tumor immunology to pathogen biology. Traffic 9: 871-81.
13. Alvarez-Erviti L, Seow Y, Schapira AH, Gardiner C, et al. 2011. Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol Dis 42: 360-7.
14. Lai RC, Arslan F, Lee MM, Sze NS, et al. 2010. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 4: 214-22.
15. Dai S, Wei D, Wu Z, Zhou X, et al. 2008. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther 16: 782-90.
16. Alvarez-Erviti L, Seow Y, Yin H, Betts C, et al. 2011. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotech 29: 341-5.
17. Armulik A, Genove G, Mae M, Nisancioglu MH, et al. 2010. Pericytes regulate the blood-brain barrier. Nature 468: 557-61.
18. Pardridge WM. 2005. The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2: 3-14.
19. Hook VY, Reisine TD. 2003. Cysteine proteases are the major beta-secretase in the regulated secretory pathway that provides most of the beta-amyloid in Alzheimer's disease: role of BACE 1 in the constitutive secretory pathway. J Neurosci Res 74: 393-405.
20. Record M, Subra C, Silvente-Poirot S, Poirot M. 2001. Exosomes as intercellular signalosomes and pharmacological effectors. Biochem Pharmacol 81: 1171-82.
21. Fairchild PJ, Nolan KF, Waldmann H. 2007. Genetic modification of dendritic cells through the directed differentiation of embryonic stem cells. Methods Mol Biol 380: 59-72.
22. Aasen T, Belmonte JC. 2010. Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells. Nat Prot 5: 371-82.
23. Karumbayaram S, Novitch BG, Patterson M, Umbach JA, et al. 2009. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells 27: 806-11.
24. Godlewski J, Nowicki MO, Bronisz A, Williams S, et al. 2008. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 68: 9125-30.
25. Kefas B, Godlewski J, Comeau L, Li Y, et al. 2008. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res 68: 3566-72.
26. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, et al. 2008. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-36.
27. Roberts RL, Fine RE, Sandra A. 1993. Receptor-mediated endocytosis of transferrin at the blood-brain barrier. J Cell Sci 104: 521-32.